Associate Director, Research Biostatistics

Provide strategic statistical leadership and methodological oversight across discovery, translational, and early research programs, ensuring robust study design, analysis, interpretation, and project decision support. Lead and perform complex statistical analyses across preclinical, translational, biomarker, imaging, omics, and human research datasets using advanced methodologies such as Bayesian methods, causal inference, longitudinal modelling, and machine learning. Develop and apply innovative statistical methods, reproducible analytical workflows, and statistical programming solutions, particularly in R and related platforms. Support biomarker identification, evaluation, and validation activities, contributing to translational evidence-generation strategies that strengthen research and portfolio decisions. Translate complex scientific data into actionable insights that support target evaluation, candidate selection, project progression, portfolio prioritisation, and probability-of-success assessments. Collaborate with Translational Bioinformatics, Global Biometrics, Data Management, PK/PD, and other quantitative functions, applying state-of-the-art statistical methodologies to address scientific challenges. Contribute to scientific publications, ethics submissions, external collaborations, and scientific communications. Mentor and develop statisticians, scientists, contractors, and interns, providing scientific leadership and fostering a culture of excellence, collaboration, and continuous learning. Champion data-driven decision making, promote statistical best practices, and deliver training to strengthen analytical capability across the organisation. Establish and manage relationships with external collaborators, academic partners, CROs, consultants, and technology providers, ensuring delivery of high-quality scientific outcomes.

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.

• PhD in Statistics, Biostatistics, or equivalent experience.

• 8+ years of experience applying statistics in a pre-clinical pharmaceutical, biotechnology, healthcare, or biomedical research environment, supporting discovery, translational, biomarker, or early development programs.

• Demonstrated track record in developing and applying advanced statistical methodologies for biological, translational, biomarker, omics, imaging, or related scientific data.

• Proven experience with modern statistical programming, reproducible analysis workflows, and quantitative computing platforms, particularly R and related technologies.

• Evidence of scientific contribution through publications, conference presentations, methodological innovations, or development of analytical tools and platforms.